Alembic Pharmaceuticals share price rose more than 3 percent in the opening trade on June 30 after the company received USFDA approval for Doxorubicin Hydrochloride Injection.At 09:21 hrs, Alembic Pharmaceuticals was quoting at Rs 1,002.80, up Rs 30.95, or 3.18 percent, on the BSE.".... has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug applicat...

Let's catch up on the latest news from the stock market. From significant investments to major deals, order wins, appointments, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Stocks to WatchJB Chemicals, Torrent PharmaceuticalsTorrent Pharma has signed definitive agreements with global investment firm KKR to acquire a controlling stake in JB Chemicals & P...

Alembic Pharma share price extended the gains on second day, rising 1 percent in the early trade on April 30 following Establishment Inspection Report (EIR) for its Panelav-based oncology formulation facility.At 09:20am, Alembic Pharmaceuticals was quoting at Rs 888.45, up Rs 9.20, or 1.05 percent, on the BSE.US Food and Drug Administration (USFDA) has carried out inspection at the said between fr...

Let's catch up on the latest news from the stock market. From significant investments to major deals, appointments, order wins and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Stocks to WatchReliance IndustriesThe company's step-down wholly owned subsidiary, Nauyaan Tradings (NTPL), has completed the acquisition of a 74% equity stake in Nauyaan Shipyard (NS...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins, appointments, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Results TodayABB IndiaQuarterly EarningsGlenmark Pharma Q3 (Consolidated YoY)Profit stands at Rs 347.96 crore Vs loss of Rs 470.14 croreRevenue grows 35.1% to Rs ...